Artiva Biotherapeutics CMO Subhashis Banerjee disposes of 429 common shares worth $5,148 under 10b5-1 plan
ARTV•Insider share sale under 10b5-1 plan
Artiva Biotherapeutics Chief Medical Officer Subhashis Banerjee sold 429 common shares on Aug. 18 at $12 apiece.
The sale followed an option exercise for 429 shares at $1.92.
Directly held common stock ended at 144,963 shares.
Employee stock options outstanding ended at 79,571.
